Age-related maculopathy: Pathogenetic features and new treatment modalities

Acta Ophthalmologica Scandinavica

Volumn 80, Issue 2, 2002, Pages 136-143

  Algvere, Peep V ^a   Seregard, Stefan ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Age related macular degeneration; Age related maculopathy; Antioxidants; Free radicals; Lipofuscin; Oxidative stress; Pathogenesis; Photodynamic therapy (PDT); Transpupillary thermotherapy (TTT)

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BENZOPORPHYRIN DERIVATIVE; BETA CAROTENE; CATALASE; ENDOTHELIAL CELL GROWTH FACTOR; FREE RADICAL; HYDROGEN PEROXIDE; LIPOFUSCIN; MELANIN; MELATONIN; OXYGEN; PEROXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR; ZINC;

AGING; ANTIOXIDANT ACTIVITY; ARGON LASER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; MEDICAL INFORMATION; MULTICENTER STUDY; OXIDATIVE STRESS; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINA ROD; RETINA SURGERY; SUBRETINAL NEOVASCULARIZATION; VITAMIN INTAKE;

AGING; CELL AGING; CLINICAL TRIALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYPERTHERMIA, INDUCED; LYMPHOKINES; MACULAR DEGENERATION; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PIGMENT EPITHELIUM OF EYE; RODS (RETINA); VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036117743     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800204.x     Document Type: Article

References (64)

1. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD
2. Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration
3. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): A study with radioactively labelled microspheres including flow determination of brain and some other tissues
4. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss
5. Macular translocation: Unifying concepts, terminology, and classification
6. Mitochondrial abnormalities in ageing macular photoreceptors
7. The role of oxidative stress in the pathogenesis of age-related macular degeneration
8. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor
9. Laser treatment in eyes with large drusen
10. The histopathologic effects of transpupillary thermotherapy in human eyes
11. Photoreceptor loss in age-related macular degeneration
12. Basal linear deposit and large drusen are specific for early age-related maculopathy
13. Accumulation of cholesterol with age in human Bruch's membrane
14. Spare rods, save the cones in ageing and age-related maculopathy
15. The retinal pigment epithelium undergoes age-related apoptosis in human eyes
16. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects
17. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration
18. Laser photocoagulation to treat macular soft drusen in age-related macular degeneration
19. CNVT Research Group The choroidal neovascularization prevention trial (CNVT): 4 year results
20. Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications
21. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
22. Age-related macular degeneration histopathological studies. The Lorenz E Zimmerman Lecture
23. Rhodopsin-mediated blue-light damage to the rat retina: Effect of photoreversal of bleaching
24. Foveal choroidal blood flow in age-related macular degeneration (AMD)
25. Anti-VEGF therapy in patients with exudative age-related macular degeneration
26. Limited macular translocation for neovascular maculopathy
27. Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light
28. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration
29. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin
30. An international classification and grading system for age-related maculopathy and macular degeneration
31. Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium
32. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
33. Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium
34. Prevalence of age-related maculopathy: The Beaver Dam Eye Study
35. Prevalence and visual consequences of macular changes in a population aged 70 years and older
36. Survival of some photoreceptor cells in albino rats following long-term exposure to continuous light
37. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration
38. Risk factors for age-related maculopathy
39. Preservation of ganglion cells layer neurons in age-related macular degeneration
40. Prevalence of age-related maculopathy in Australia: The Blue Mountain Eye Study
41. Pigment epithelium-derived growth factor inhibits retinal and choroidal neovascularization
42. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularization
43. Upregulation of pigment epithelium-derived factor after laser photocoagulation
44. Psychophysical evidence for rod vulnerability in age-related macular degeneration
45. Ageing changes in Bruch's membrane. A histochemical and morphological study
46. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study)
47. Transpupillary thermotherapy of occult subfoveal neovascularization in patients with age-related macular degeneration
48. Morphology of early choroidal neovascularization in age-related macular degeneration
49. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin
50. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin
51. Risk factors for age-related macular degeneration. Pooled findings from three continents
52. The macular pigment. II. Spatial distribution in primate retinas
53. Blue light-induced apoptosis of A2E-containing RPE: Involvement of caspase-3 and protection by Bcl-2
54. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes
55. Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content
56. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin
57. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes
58. The prevalence of age-related maculopathy
59. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal Verteporfin in Photodynamic Therapy Report No. 2
60. Age-related macular degeneration: Macular changes, prevalence, and sex ratio: An epidemiological study of 1000 aged individuals
61. The prevalence of age-related maculopathy in the Rotterdam study
62. Prevention of photoreceptor apoptosis by activation of the glucocorticoid factor
63. Blue light induced apoptosis in rat retina